ASX
Anagenics Limited
AN1:ASX•Consumer Defensive
Sensitive ASX Announcement
CELLMID'S USA MIDKINE PATENT FOR ALOPECIA ALLOWED
Published: 31/01/17, 10:13am (AEST)•2 pages